Current evidence is more reassuring than older warnings suggested, but it is not a reason to treat testosterone casually. TRAVERSE supports cardiovascular safety regarding major events in appropriately selected men, while FDA labeling keeps blood pressure and other risks in view.
Read the Blog :...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)